Mycophenolate mofetil for drug-induced vanishing bile duct syndrome

World Journal of Gastroenterology

Volumn 13, Issue 45, 2007, Pages 6087-6089

  Jakab, S Simona ^a   West, A Brian ^b   Meighan, Dennis M ^a   Brown Jr , Robert S ^c   Hale, William B ^a  

^a NORWALK HOSPITAL   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Amoxicillin and clavulanate; Drug induced cholestasis; Ductopenia; Mycophenolate mofetil; Vanishing bile duct syndrome

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; URSODEOXYCHOLIC ACID;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; BILE DUCT DISEASE; BRONCHITIS; CASE REPORT; CHOLESTASIS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; RECURRENT DISEASE; VANISHING BILE DUCT SYNDROME;

EID: 36949039193     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.13.6087     Document Type: Article

References (17)

1. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ. Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327-1332
2. Reddy KR, Brillant P, Schiff ER. Amoxicillin-clavulanate potassium-associated cholestasis. Gastroenterology 1989; 96: 1135-1141
3. Larrey D, Erlinger S. Drug-induced cholestasis. Baillieres Clin Gastroenterol 1988; 2: 423-452
4. Desmet VJ. Vanishing bile duct syndrome in drug-induced liver disease. J Hepatol 1997; 26 Suppl 1: 31-35
5. Chawla A, Kahn E, Yunis EJ, Daum F. Rapidly progressive cholestasis: An unusual reaction to amoxicillin/clavulanic acid therapy in a child. J Pediatr 2000; 136:121-123
6. Ferrando Vela J, Sanz Moncasi P, Sevilla Redondo G, Figueras Villalba P, Martin Algora I. Hepatic failure secondary to hepatitis due to amoxicillin-clavulanic acid. Treatment with corticoids. An Med Interna 2002; 19: 551-552
7. Ludwig J, Wiesner RH, LaRusso NF. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol 1988; 7: 193-199
8. Hubscher SG, Buckels JA, Ehas E, McMaster P, Neuberger J. Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation 1991; 51: 1004-1010
9. Hautekeete ML, Horsmans Y, Van Waeyenberge C, Demanet C, Henrion J, Verbist L, Brenard R, Sempoux C, Michielsen PP, Yap PS, Rahier J, Geubel AP. HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology 1999; 117: 1181-1186
10. O'Donohue J, Oien KA, Donaldson P, Underhill J, Clare M, MacSween RN, Mills PR. Co-amoxiclav jaundice: clinical and histological features and HLA class II association. Gut 2000; 47:717-720
11. Hautekeete ML, Brenard R, Horsmans Y, Henrion J, Verbist L, Derue G, Druez P, Omar M, Kockx M, Hubens H. Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. J Hepatol 1995; 22: 71-77
12. Larrey D, Vial T, Micaleff A, Babany G, Morichau-Beauchant M, Michel H, Benhamou JP. Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut 1992; 33: 368-371
13. Richardet JP, Mallat A, Zafrani ES, Blazquez M, Bognel JC, Campillo B. Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid. Dig Dis Sci 1999; 44:1997-2000
14. Ryley NG, Fleming KA, Chapman RW. Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin). J Hepatol 1995; 23: 278-282
15. Degott C, Feldmann G, Larrey D, Durand-Schneider AM, Grange D, Machayekhi JP, Moreau A, Potet F, Benhamou JP. Drug-induced prolonged cholestasis in adults: a histological serniquantitative study demonstrating progressive ductopenia. Hepatology 1992; 15: 244-251
16. Devlin SM, Swain MG, Urbanski SJ, Burak KW. Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy. Can J Gastroenterol 2004; 18: 321-326
17. Richardson PD, James PD, Ryder SD. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000; 33: 371-375